Blood Cancer Journal (Mar 2025)
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
- James A. Davis,
- Jordan Snyder,
- Mikhaila Rice,
- Donald C. Moore,
- Christopher Cahoon,
- Kelley Julian,
- Charlotte B. Wagner,
- Katelynn Granger,
- Kimberly M. Green,
- Shebli Atrash,
- Hailey Hill,
- Jessica McElwee,
- Grace Elsey,
- Jack Khouri,
- Joslyn Rudoni,
- Zahra Mahmoudjafari,
- Victoria R. Nachar
Affiliations
- James A. Davis
- Hollings Cancer Center, The Medical University of South Carolina
- Jordan Snyder
- University of Kansas Cancer Center
- Mikhaila Rice
- Taussig Cancer Center, Cleveland Clinic
- Donald C. Moore
- Levine Cancer Institute
- Christopher Cahoon
- Huntsman Cancer Institute, University of Utah
- Kelley Julian
- Huntsman Cancer Institute, University of Utah
- Charlotte B. Wagner
- Huntsman Cancer Institute, University of Utah
- Katelynn Granger
- Hollings Cancer Center, The Medical University of South Carolina
- Kimberly M. Green
- Hollings Cancer Center, The Medical University of South Carolina
- Shebli Atrash
- Levine Cancer Institute
- Hailey Hill
- Levine Cancer Institute
- Jessica McElwee
- Levine Cancer Institute
- Grace Elsey
- Levine Cancer Institute
- Jack Khouri
- Taussig Cancer Center, Cleveland Clinic
- Joslyn Rudoni
- Taussig Cancer Center, Cleveland Clinic
- Zahra Mahmoudjafari
- University of Kansas Cancer Center
- Victoria R. Nachar
- University of Michigan Rogel Cancer Center
- DOI
- https://doi.org/10.1038/s41408-025-01222-y
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 5
Abstract
No abstracts available.